NO20021993D0 - Redox reversible HCV proteins with native-like conformation - Google Patents

Redox reversible HCV proteins with native-like conformation

Info

Publication number
NO20021993D0
NO20021993D0 NO20021993A NO20021993A NO20021993D0 NO 20021993 D0 NO20021993 D0 NO 20021993D0 NO 20021993 A NO20021993 A NO 20021993A NO 20021993 A NO20021993 A NO 20021993A NO 20021993 D0 NO20021993 D0 NO 20021993D0
Authority
NO
Norway
Prior art keywords
conformation
native
hcv proteins
redox reversible
redox
Prior art date
Application number
NO20021993A
Other languages
Norwegian (no)
Other versions
NO20021993L (en
Inventor
Alfons Bosman
Erik Depla
Geert Maertens
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2000/010499 external-priority patent/WO2001030815A1/en
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Publication of NO20021993D0 publication Critical patent/NO20021993D0/en
Publication of NO20021993L publication Critical patent/NO20021993L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/18—Togaviridae; Flaviviridae
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20021993A 1999-10-27 2002-04-26 Redox reversible HCV proteins with a conformation similar to native NO20021993L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99870225 1999-10-27
US16928899P 1999-12-07 1999-12-07
PCT/EP2000/010499 WO2001030815A1 (en) 1999-10-27 2000-10-25 Redox reversible hcv proteins with native-like conformation

Publications (2)

Publication Number Publication Date
NO20021993D0 true NO20021993D0 (en) 2002-04-26
NO20021993L NO20021993L (en) 2002-06-27

Family

ID=26153862

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021993A NO20021993L (en) 1999-10-27 2002-04-26 Redox reversible HCV proteins with a conformation similar to native

Country Status (4)

Country Link
KR (1) KR20020047286A (en)
HK (1) HK1049847A1 (en)
IL (1) IL148931A0 (en)
NO (1) NO20021993L (en)

Also Published As

Publication number Publication date
KR20020047286A (en) 2002-06-21
NO20021993L (en) 2002-06-27
HK1049847A1 (en) 2003-05-30
IL148931A0 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
DE60019547D1 (en) biosensor
DE60004785D1 (en) REVERSIBLE INDEPENDENT COOKING UNIT
DE60011853D1 (en) syringe
ATE263748T1 (en) ADMANTANE DERIVATIVES
PT1240172E (en) NEW AMINOPROPYLPHOSPHINIC ACIDS
PT1060695E (en) EMPILHAVEL CHAIR
DK1244641T3 (en) Thiazolyl amide derivatives
NO20020526L (en) Moxifloxase information formulation with saline
ATE459356T1 (en) INDOLYL-3-GLYOXYLIC ACID DERIVATIVES WITH THERAPEUTIC VALUABLE PROPERTIES
ATE270270T1 (en) NOVEL PHENYLALKYLOXY-PHENYL DERIVATIVES
ATE257148T1 (en) PROPARGYLETHER DERIVATIVES
DE50005284D1 (en) SUBSTITUTED N-BENZYL-INDOL-3-YL-GLYOXYLIC ACID DERIVATIVES WITH ANTITUARY EFFECT
EE200100708A (en) Substituted phenoxyacetic acids
NO20032614D0 (en) Pharmaceutical composition with improved absorbability
ATE273272T1 (en) MEVINOLINE DERIVATIVES
DK1218304T3 (en) Glass Composition
NO20020155L (en) Aminothiazole derivatives and their use as CRF receptor ligands
ATE254598T1 (en) 4-HYDROXYBIPHENYLHYDRAZIDE DERIVATIVES
ATE241622T1 (en) THIAZOLIDINDONE DERIVATIVES AS ANTIDIABETICS
HUP0203195A3 (en) Redox reversible hcv proteins with native-like conformation
FR2791348B1 (en) POLYPEPTIDE Npt2B
NO20021993D0 (en) Redox reversible HCV proteins with native-like conformation
ID25567A (en) SCREW-CLOSED WITH SHOULDER-TWIN
DE50014800D1 (en) GLASS NOODLE
DE10082298D2 (en) Chimeric proteins

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application